Literature DB >> 1585257

Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies.

S Caldecott-Hazard1, L S Schneider.   

Abstract

The present document is the final of three parts of a review that focuses on recent data from clinical and animal research concerning the biochemical bases of depressive disorders, diagnosis, and treatment. Various treatments for depression, including psychotherapy, pharmacological, and somatic treatments, will be described in this third part. Also, some of the controversies in the field, as well as a summary of the most salient points of the review, will be discussed. Previous sections of this review dealt with the classification of depressive disorders and research techniques for studying the biochemical mechanisms of these disorders (Part I) and various transmitter/receptor theories of depressive disorder (Part II).

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1585257     DOI： 10.1002/syn.890100209

Source DB:  PubMed          Journal:  Synapse        ISSN： 0887-4476            Impact factor:   2.562


  8 in total

Review 1.  Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Authors:  Joanna S Fowler; Jean Logan; Nora D Volkow; Gene-Jack Wang
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

2.  Absence of stereoselectivity of some tricyclic antidepressants for the inhibition of depolarization-induced calcium uptake in rat cingulate cortex synaptosomes.

Authors:  P A Lavoie; G Beauchamp; R Elie
Journal:  J Psychiatry Neurosci       Date:  1994-05       Impact factor: 6.186

Review 3.  The role of serotonin receptor subtypes in treating depression: a review of animal studies.

Authors:  Gregory V Carr; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-11-24       Impact factor: 4.530

4.  Brain monoamine oxidase A inhibition in cigarette smokers.

Authors:  J S Fowler; N D Volkow; G J Wang; N Pappas; J Logan; C Shea; D Alexoff; R R MacGregor; D J Schlyer; I Zezulkova; A P Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  Low monoamine oxidase B in peripheral organs in smokers.

Authors:  Joanna S Fowler; Jean Logan; Gene-Jack Wang; Nora D Volkow; Frank Telang; Wei Zhu; Dinko Franceschi; Naomi Pappas; Richard Ferrieri; Colleen Shea; Victor Garza; Youwen Xu; David Schlyer; S John Gatley; Yu-Shin Ding; David Alexoff; Donald Warner; Noelwah Netusil; Pauline Carter; Millard Jayne; Payton King; Paul Vaska
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

6.  Brain monoamine oxidase A activity predicts trait aggression.

Authors:  Nelly Alia-Klein; Rita Z Goldstein; Aarti Kriplani; Jean Logan; Dardo Tomasi; Benjamin Williams; Frank Telang; Elena Shumay; Anat Biegon; Ian W Craig; Fritz Henn; Gene-Jack Wang; Nora D Volkow; Joanna S Fowler
Journal:  J Neurosci       Date:  2008-05-07       Impact factor: 6.167

7.  Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.

Authors:  Athina Markou; Paul J Kenny
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

8.  Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.

Authors:  Olivia F O'Leary; Anita J Bechtholt; James J Crowley; Tiffany E Hill; Michelle E Page; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2007-02-21       Impact factor: 4.415
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.